Cologne, North Rhine-Westphalia, Germany
I’m a strategic and science-driven Business Development leader with 15+ years of experience across biotech and pharma, specializing in in-/out-licensing, strategic alliances, and platform-based partnerships that drive growth. Over the course of my career, I’ve led and closed deals across immunology, neurology, oncology, and rare diseases, collaborating with partners ranging from early-stage biotechs to Big Pharma. I bring a proven track record of translating innovation into impactful medicines and the ability to bridge cultures, technologies, and geographies — from EU/US to Asia. Currently, as VP Business Development at Secarna Pharmaceuticals, I’m helping to expand partnering activities around a leading antisense oligonucleotide (ASO) platform, advancing next-generation RNA therapeutics and enabling partnerships that create lasting value. I thrive at the intersection of science, strategy, and entrepreneurship — turning ideas into opportunities and partnerships into impact. Always open to connecting with innovators, dealmakers, and investors shaping the next wave of biotech.
Driving strategic partnerships and collaborations to advance Secarna’s antisense oligonucleotide (ASO) platform and pipeline. Delivering growth through strategic alliances and value-driven transactions.
Supported early-stage biotechs & entrepreneurs on BD strategy, partnering readiness, transactions & asset positioning.
Driving mid- and late-stage partnerships globally in Rare Diseases and Global Public Health with a specific focus on Tuberculosis. Facilitating breakthrough innovation through collaborations with pharma, biotech, foundations, and NGOs for the world’s toughest health challenges.
Led early partnering and search & evaluation across therapeutic areas. Forged strategic alliances with startups, researchers, and biotech companies, driving Janssen's Strategic Alliance strategy with an innovation focus on Germany.
LDC is a translational incubator professionally developing and commercializing drug discovery innovation coming out of academia Oversaw BD, Out-licensing, and Alliance Management. Notable deals include licenses with Sotio and Boehringer Ingelheim, and discovery alliances with Roche and Infinity. PLG Business Development Newcomer of the Year Award 2013 Nominee.
Key role in the start-up phase, handling BD, Operations, Legal, IP, and PR. Built extensive networks, managed out-licensing, and directed operational setup of labs.
Played a vital role as a project manager in facilitating the setup of a translational Drug Discovery & Development Center for the Max Planck Society. Successful initiative that led to the formation of the spinout company Lead Discovery Center GmbH. Secured 20€ Mio funding through a German BMBF grant.
Managed the commercialization of a portfolio of 10 early-stage technology assets. Support of several start-up teams. Closed one option and one license agreement.